A New Testament for the Followers of Thymic Epithelial Tumors

Abstract

Get full access to this article

View all access options for this article.

References

. Decision-making in surgical treatment for stand-alone atrial fibrillation: minimally invasive Cox maze procedure. Innovations 2019; 14: 487–492.doi:10.1177/1556984519884534

http://www.ncbi.nlm.nih.gov/pubmed/31840572

Schäfers

H-J

. The 10 commandments for aortic valve repair. Innovations 2019; 14: 188–198.doi:10.1177/1556984519843909

http://www.ncbi.nlm.nih.gov/pubmed/31050324

Engels

. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 2010; 5(10 Suppl 4): S260–S265.doi:10.1097/JTO.0b013e3181f1f62d

http://www.ncbi.nlm.nih.gov/pubmed/20859116

Patton

DF.

Ribeiro

RC.

Jenkins

et al. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator. J Infect Dis 1994; 170: 7–12.doi:10.1093/infdis/170.1.7

http://www.ncbi.nlm.nih.gov/pubmed/8014523

Girard

Mornex

Van Houtte

et al. Thymoma: a focus on current therapeutic management. J Thorac Oncol 2009; 4: 119–126.doi:10.1097/JTO.0b013e31818e105c

http://www.ncbi.nlm.nih.gov/pubmed/19096319

Regnard

JF.

Magdeleinat

Dromer

et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376–384.doi:10.1016/S0022-5223(96)70265-9

http://www.ncbi.nlm.nih.gov/pubmed/8751506

Venuta

Rendina

EA.

Longo

et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003; 76: 1866–1872.doi:10.1016/S0003-4975(03)01020-8

http://www.ncbi.nlm.nih.gov/pubmed/14667602

Pan

CC.

Chen

PC.

Wang

et al. Thymoma is associated with an increased risk of second malignancy. Cancer 2001; 92: 2406–2411.doi:10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7

http://www.ncbi.nlm.nih.gov/pubmed/11745297

Engels

EA.

Pfeiffer

. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003; 105: 546–551.doi:10.1002/ijc.11099

http://www.ncbi.nlm.nih.gov/pubmed/12712448

10.

Abbas

. Commentary: extrapleural pneumonectomy during myasthenic crisis. The urge to go big or go home. JTCVS Techniques 2020.doi:10.1016/j.xjtc.2020.03.033

11.

Thomas

CR.

Wright

CD.

Loehrer

. Thymoma: state of the art. J Clin Oncol 1999; 17: 2280–2289.doi:10.1200/JCO.1999.17.7.2280

http://www.ncbi.nlm.nih.gov/pubmed/10561285

12.

Berrouschot

Baumann

Kalischewski

et al. Therapy of myasthenic crisis. Crit Care Med 1997; 25: 1228–1235.doi:10.1097/00003246-199707000-00027

http://www.ncbi.nlm.nih.gov/pubmed/9233752

13.

Ando

Omasa

Kondo

et al. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis. Eur J Cardiothorac Surg 2015; 48: 705–709.doi:10.1093/ejcts/ezu530

http://www.ncbi.nlm.nih.gov/pubmed/25618314

14.

Leuzzi

Meacci

Cusumano

et al. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis. Eur J Cardiothorac Surg 2014; 45: e76–e88.doi:10.1093/ejcts/ezt641

http://www.ncbi.nlm.nih.gov/pubmed/24525106

15.

Watanabe

Obama

et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 2004; 127: 868–876.doi:10.1016/j.jtcvs.2003.07.036

http://www.ncbi.nlm.nih.gov/pubmed/15001919

16.

de Perrot

Liu

Bril

et al. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 2002; 74: 1658–1662.doi:10.1016/S0003-4975(02)04083-3

http://www.ncbi.nlm.nih.gov/pubmed/12440626

17.

Jaretzki

Wolff

. “Maximal” thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 1988; 96: 711–716.http://www.ncbi.nlm.nih.gov/pubmed/3184965

18.

Zielinski

Kuzdzal

Nabialek

. Transcervical-subxiphoid-VATS “maximal” thymectomy for myasthenia gravis. Multimed Man Cardiothorac Surg 2005; 2005: mmcts.2004.000836.doi:10.1510/mmcts.2004.000836

http://www.ncbi.nlm.nih.gov/pubmed/24414331

19.

Sanders

DB.

Wolfe

GI.

Benatar

et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 2016; 87: 419–425.doi:10.1212/WNL.0000000000002790

27358333

20.

Onuki

Ueda

Otsu

et al. Thymectomy during myasthenic crisis under artificial respiration. Ann Thorac Cardiovasc Surg 2019; 25: 215–218.doi:10.5761/atcs.cr.17-00176

http://www.ncbi.nlm.nih.gov/pubmed/29515082

21.

Iqbal

Shokrzadeh

Nawgiri

et al. Extrapleural pneumonectomy with en bloc myocardial resection for advanced thymoma. JTCVS Techniques 2020.doi:10.1016/j.xjtc.2020.03.032

22.

Marx

Müller-Hermelink

. From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The second conference on biological and clinical aspects of thymic epithelial tumors and related recent developments. Pathol Res Pract 1999; 195: 515–533.doi:10.1016/s0344-0338(99)80001-6

http://www.ncbi.nlm.nih.gov/pubmed/10483582

23.

Rena

Papalia

Maggi

et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005; 50: 59–66.doi:10.1016/j.lungcan.2005.05.009

http://www.ncbi.nlm.nih.gov/pubmed/16009453

24.

Okumura

Ohta

Tateyama

et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002; 94: 624–632.doi:10.1002/cncr.10226

http://www.ncbi.nlm.nih.gov/pubmed/11857293

25.

Pescarmona

Rendina

EA.

Venuta

et al. The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am J Clin Pathol 1990; 93: 190–195.doi:10.1093/ajcp/93.2.190

http://www.ncbi.nlm.nih.gov/pubmed/2301282

26.

Moran

CA.

Weissferdt

Kalhor

et al. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol 2012; 137: 444–450.doi:10.1309/AJCP76KEGWQKWOKA

http://www.ncbi.nlm.nih.gov/pubmed/22338057

27.

Filosso

PL.

Ruffini

Lausi

et al. Historical perspectives: the evolution of the thymic epithelial tumors staging system. Lung Cancer 2014; 83: 126–132.doi:10.1016/j.lungcan.2013.09.013

http://www.ncbi.nlm.nih.gov/pubmed/24377980

28.

Masaoka

Monden

Nakahara

et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–2492.doi:10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R

http://www.ncbi.nlm.nih.gov/pubmed/7296496

29.

Koga

Matsuno

Noguchi

et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994; 44: 359–367.doi:10.1111/j.1440-1827.1994.tb02936.x

http://www.ncbi.nlm.nih.gov/pubmed/8044305

30.

Detterbeck

FC.

Stratton

Giroux

et al. The IASLC/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014; 9(9 Suppl 2): S65–S72.doi:10.1097/JTO.0000000000000290

http://www.ncbi.nlm.nih.gov/pubmed/25396314

31.

Carter

BW.

Okumura

Detterbeck

et al. Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol 2014; 9(9 Suppl 2): S110–S118.doi:10.1097/JTO.0000000000000295

http://www.ncbi.nlm.nih.gov/pubmed/25396307

32.

Takahashi

Al-Janabi

. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 2010; 32: 1325–1339.doi:10.1002/jmri.22377

http://www.ncbi.nlm.nih.gov/pubmed/21105138

33.

Abdel Razek

AAK.

Khairy

Nada

. Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging. Radiology 2014; 273: 268–275.doi:10.1148/radiol.14131643

http://www.ncbi.nlm.nih.gov/pubmed/24877982

34.

Inaoka

Takahashi

Mineta

et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243: 869–876.doi:10.1148/radiol.2433060797

http://www.ncbi.nlm.nih.gov/pubmed/17463136

35.

Ackman

JB.

. MRI of the thymus. AJR Am J Roentgenol 2011; 197: W15–W20.doi:10.2214/AJR.10.4703

http://www.ncbi.nlm.nih.gov/pubmed/21700977

36.

Endo

Nakagawa

Ohde

et al. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008; 61: 350–355.doi:10.1016/j.lungcan.2008.01.003

http://www.ncbi.nlm.nih.gov/pubmed/18304691

37.

Kaira

Murakami

Miura

et al. 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med 2011; 25: 247–253.doi:10.1007/s12149-010-0455-x

http://www.ncbi.nlm.nih.gov/pubmed/21174178

38.

Guidoccio

Grosso

Maccauro

et al. Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses. Tumori 2011; 97: 191–195.doi:10.1177/030089161109700210

http://www.ncbi.nlm.nih.gov/pubmed/21617714

39.

Girard

Shen

Guo

et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 2009; 15: 6790–6799.doi:10.1158/1078-0432.CCR-09-0644

http://www.ncbi.nlm.nih.gov/pubmed/19861435

40.

Schirosi

Nannini

Nicoli

et al. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. Ann Oncol 2012; 23: 2409–2414.doi:10.1093/annonc/mdr626

http://www.ncbi.nlm.nih.gov/pubmed/22357254

41.

Marchevsky

Marx

Ströbel

et al. Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol 2011; 6(7 Suppl 3): S1724–S1729.doi:10.1097/JTO.0b013e31821ea57c

http://www.ncbi.nlm.nih.gov/pubmed/21847054

42.

Blumberg

Port

JL.

Weksler

et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60: 908–914.doi:10.1016/0003-4975(95)00669-C

http://www.ncbi.nlm.nih.gov/pubmed/7574993

43.

Nakagawa

Asamura

Matsuno

et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003; 126: 1134–1140.doi:10.1016/S0022-5223(03)00798-0

http://www.ncbi.nlm.nih.gov/pubmed/14566259

44.

Shen

et al. Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis. J Thorac Dis 2016; 8: 680–686.doi:10.21037/jtd.2016.03.16

http://www.ncbi.nlm.nih.gov/pubmed/27114835

45.

Toker

Sonett

Zielinski

et al. Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol 2011; 6(7 Suppl 3): S1739–S1742.doi:10.1097/JTO.0b013e31821ea553

http://www.ncbi.nlm.nih.gov/pubmed/21847056

46.

Detterbeck

FC.

Moran

Huang

et al. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 2011; 6(7 Suppl 3): S1730–S1738.doi:10.1097/JTO.0b013e31821ea567

http://www.ncbi.nlm.nih.gov/pubmed/21847055

47.

Kondo

Monden

. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 2003; 76: 1859–1864.doi:10.1016/S0003-4975(03)01017-8

http://www.ncbi.nlm.nih.gov/pubmed/14667600

48.

Mazzei

Abbas

. Why comprehensive adoption of robotic assisted thoracic surgery is ideal for both simple and complex lung resections. J Thorac Dis 2020; 12: 70–81.doi:10.21037/jtd.2020.01.22

http://www.ncbi.nlm.nih.gov/pubmed/32190356

49.

Chen

Zhang

Jin

et al. Robot-assisted thoracoscopic surgery for mediastinal masses: a single-institution experience. J Thorac Dis 2020; 12: 105–113.doi:10.21037/jtd.2019.08.105

http://www.ncbi.nlm.nih.gov/pubmed/32190360

50.

Qian

Chen

Huang

et al. A comparison of three approaches for the treatment of early-stage thymomas: robot-assisted thoracic surgery, video-assisted thoracic surgery, and median sternotomy. J Thorac Dis 2017; 9: 1997–2005.doi:10.21037/jtd.2017.06.09

http://www.ncbi.nlm.nih.gov/pubmed/28839999

51.

Yang

CJ.

Kumar

Klapper

et al. A national analysis of long-term survival following thoracoscopic versus open lobectomy for Stage I non-small-cell lung cancer. Ann Surg 2019; 269: 163–171.doi:10.1097/SLA.0000000000002342

http://www.ncbi.nlm.nih.gov/pubmed/28799982

52.

Agasthian

. Can invasive thymomas be resected by video-assisted thoracoscopic surgery? Asian Cardiovasc Thorac Ann 2011; 19(3-4): 225–227.doi:10.1177/0218492311407977

http://www.ncbi.nlm.nih.gov/pubmed/21885546

53.

Kneuertz

PJ.

Kamel

MK.

Stiles

et al. Robotic thymectomy is feasible for large thymomas: a propensity-matched comparison. Ann Thorac Surg 2017; 104: 1673–1678.doi:10.1016/j.athoracsur.2017.05.074

http://www.ncbi.nlm.nih.gov/pubmed/28935345

54.

Friedant

AJ.

Handorf

EA.

et al. Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis. J Thorac Oncol 2016; 11: 30–38.doi:10.1016/j.jtho.2015.08.004

http://www.ncbi.nlm.nih.gov/pubmed/26762737

55.

Wright

. Extended resections for thymic malignancies. J Thorac Oncol 2010; 5(10 Suppl 4): S344–S347.doi:10.1097/JTO.0b013e3181f20eb3

http://www.ncbi.nlm.nih.gov/pubmed/20859130

56.

Regnard

JF.

Zinzindohoue

Magdeleinat

et al. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997; 64: 1593–1598.doi:10.1016/S0003-4975(97)01175-2

http://www.ncbi.nlm.nih.gov/pubmed/9436541

57.

Venuta

Rendina

. Superior vena cava resection and reconstruction. Eur J Cardiothorac Surg 2012; 41: 1177–1178.doi:10.1093/ejcts/ezr266

http://www.ncbi.nlm.nih.gov/pubmed/22290902

58.

Ried

Marx

Götz

et al. State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2016; 49: 1545–1552.doi:10.1093/ejcts/ezv426

http://www.ncbi.nlm.nih.gov/pubmed/26670806

59.

Shapiro

Korst

. Surgical approaches for Stage IVA thymic epithelial tumors. Front Oncol 2014; 3: 332.doi:10.3389/fonc.2013.00332

http://www.ncbi.nlm.nih.gov/pubmed/24459636

60.

Huang

Rizk

NP.

Travis

et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007; 134: 1477–1484.doi:10.1016/j.jtcvs.2007.07.049

http://www.ncbi.nlm.nih.gov/pubmed/18023668

61.

Wright

. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006; 82: 1234–1239.doi:10.1016/j.athoracsur.2006.05.028

http://www.ncbi.nlm.nih.gov/pubmed/16996913

62.

Ishikawa

Matsuguma

Nakahara

et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009; 88: 952–957.doi:10.1016/j.athoracsur.2009.05.019

http://www.ncbi.nlm.nih.gov/pubmed/19699926

63.

Yang

HC.

Yoon

YS.

Kim

et al. En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg 2011; 6: 28.doi:10.1186/1749-8090-6-28

http://www.ncbi.nlm.nih.gov/pubmed/21396119

64.

Rena

Mineo

TC.

Casadio

. Multimodal treatment for stage IVA thymoma: a proposable strategy. Lung Cancer 2012; 76: 89–92.doi:10.1016/j.lungcan.2011.10.004

http://www.ncbi.nlm.nih.gov/pubmed/22030450

65.

Girard

. Thymic epithelial tumours: from basic principles to individualised treatment strategies. Eur Respir Rev 2013; 22: 75–87.doi:10.1183/09059180.00007312

http://www.ncbi.nlm.nih.gov/pubmed/23457169

66.

Petrov

Bakhos

Abbas

. Management of malignant lung entrapment, the oncothorax. Thorac Surg Clin 2018; 28: 81–90.doi:10.1016/j.thorsurg.2017.08.009

http://www.ncbi.nlm.nih.gov/pubmed/29150040

67.

Mornex

Resbeut

Richaud

et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 1995; 32: 651–659.doi:10.1016/0360-3016(95)00079-e

http://www.ncbi.nlm.nih.gov/pubmed/7790251

68.

Kondo

Monden

. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003; 76: 878–884.doi:10.1016/S0003-4975(03)00555-1

http://www.ncbi.nlm.nih.gov/pubmed/12963221

69.

Abbas

. Robotic portal lobectomy, surgery through a virtual thoracotomy. J Thorac Dis 2017; 9: 2871–2875.doi:10.21037/jtd.2017.08.84

http://www.ncbi.nlm.nih.gov/pubmed/29220042

70.

Toker

Kaba

Ayalp

et al. Minimally invasive resection of thymoma. Mediastinum 2018; 2: 36.doi:10.21037/med.2018.04.02

71.

Rückert

JC.

Swierzy

Ismail

. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. J Thorac Cardiovasc Surg 2011; 141: 673–677.doi:10.1016/j.jtcvs.2010.11.042

http://www.ncbi.nlm.nih.gov/pubmed/21335125

72.

Sanei

Tabatabie

SA.

Bigdelian

et al. Distribution of mediastinal ectopic thymic tissue in patients without thymic disease. Adv Biomed Res 2015; 4: 18.doi:10.4103/2277-9175.149849

http://www.ncbi.nlm.nih.gov/pubmed/25709983

73.

Weydert

JA.

De Young

BR.

Leslie

et al. Recommendations for the reporting of surgically resected thymic epithelial tumors. Hum Pathol 2009; 40: 918–923.doi:10.1016/j.humpath.2009.03.012

http://www.ncbi.nlm.nih.gov/pubmed/19524103

74.

Loehrer

PJ.

Wang

Johnson

et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 2004; 22: 293–299.doi:10.1200/JCO.2004.02.047

http://www.ncbi.nlm.nih.gov/pubmed/14722038

75.

Schalke

Boy

Hofmann

H-S

et al. Neoadjuvant treatment of primary inoperable or local recurrent thymoma with octreotide LAR to improve tumor resectability. J Clin Oncol 2012; 30(15_suppl): 7105–7105.doi:10.1200/jco.2012.30.15_suppl.7105

76.

Girard

. Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther 2012; 12: 685–695.doi:10.1586/era.12.29

http://www.ncbi.nlm.nih.gov/pubmed/22594902

77.

Yokoyama

Miyoshi

. Thymic tumors and immune checkpoint inhibitors. J Thorac Dis 2018; 10(Suppl 13): S1509–S1515.doi:10.21037/jtd.2017.10.157

http://www.ncbi.nlm.nih.gov/pubmed/29951302

78.

Ahmad

Huang

. Current readings: The most influential and recent studies involving surgical management of thymoma. Semin Thorac Cardiovasc Surg 2013; 25: 144–149.doi:10.1053/j.semtcvs.2013.05.001

http://www.ncbi.nlm.nih.gov/pubmed/24216530

79.

Giaccone

Wilmink

Paul

et al. Systemic treatment of malignant thymoma: a decade experience at a single institution. Am J Clin Oncol 2006; 29: 336–344.doi:10.1097/01.coc.0000227481.36109.e7

http://www.ncbi.nlm.nih.gov/pubmed/16891859

80.

Rena

Papalia

Oliaro

et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg 2007; 31: 109–113.doi:10.1016/j.ejcts.2006.10.022

http://www.ncbi.nlm.nih.gov/pubmed/17110124

81.

Myojin

Choi

NC.

Wright

et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000; 46: 927–933.doi:10.1016/S0360-3016(99)00514-3

http://www.ncbi.nlm.nih.gov/pubmed/10705015

82.

Ströbel

Bauer

Puppe

et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004; 22: 1501–1509.doi:10.1200/JCO.2004.10.113

http://www.ncbi.nlm.nih.gov/pubmed/15084623